Generic Drug Market in Canada

Table of Contents

1. Analyst View

2. Macroeconomic and Healthcare Factors

• 2.1 Macroeconomic Indicators
• 2.2 Population Profile
• 2.3 Age Profile
• 2.4 Healthcare Spending and Infrastructure

3. Pharmaceutical Market

• 3.1 Market Size and Growth
  • 3.1.1 Prescriptions
  • 3.1.2 Sales
• 3.2 By Therapeutic Category
• 3.3 By Drug Category
• 3.4 Healthcare Expenditure
• 3.5 Top Selling Drugs
  • 3.5.1 Prescriptions
  • 3.5.2 Sales

4. Generics Market Attractions

• 4.1 Favorable Political Environment
• 4.2 Aging Population
• 4.3 Patent Expiration
• 4.4 High Returns for Pharmacists
• 4.5 Huge Cost Savings

5. Generics Market

• 5.1 Market Size and Growth
  • 5.1.1 Prescriptions
  • 5.1.2 Sales
• 5.2 By Province/Territories
  • 5.2.1 Drug Consumption
  • 5.2.2 Prescriptions
  • 5.2.3 Sales
• 5.3 Market Segmentation
  • 5.3.1 Retail Pharmacies
  • 5.3.1.1 Sales
  • 5.3.2 Hospital Pharmacies
  • 5.3.2.1 Sales
  • 5.3.3 Authorized and Independent Generics
  • 5.3.4 Distribution Channels

6. Generics Market - Opportunity Areas

• 6.1 Cardiovascular Drugs
• 6.2 Psychotherapeutics
• 6.3 Cholesterol Agents
• 6.4 Antidiabetics

7. Forecast for Branded and Generic Drug to 2013

8. Key Players

• 8.1 Pharmaceutical Market
  • 8.1.1 Prescriptions
  • 8.1.2 Sales
• 8.2 Generics Market
  • 8.2.1 Prescriptions
  • 8.2.2 Sales
  • 8.2.3 Retail Pharmacies
  • 8.2.4 Hospital Pharmacies

9. General Approval Process

• 9.1 Abbreviated New Drug Submission
• 9.2 Notice of Allegation

10. Industry Roadblock

• 10.1 Extension of Data Exclusivity
• 10.2 Ever-greening of Drug Patents
• 10.3 Authorized Generics

List of Figures:

• Figure 2-1: Nominal GDP (Billion US$), 2002-2008
• Figure 2-2: Consumer Price Index (%), 2002-2008
• Figure 2-3: Forecast for Consumer Price Index (%), 2009-2013
• Figure 2-4: Currency Exchange Rate (From CAD to US$), 2002-2008
• Figure 2-5: Population (Million), 2002-2008
• Figure 2-6: Forecast for Population (Million), 2009-2013
• Figure 2-7: Life Expectancy (Years), 2002-2008
• Figure 2-8: Forecast for Life Expectancy (Years), 2009-2013
• Figure 2-9: Population Breakup by Age Group (%), 2002-2008
• Figure 2-10: Forecast for Population Breakup by Age Group (%), 2009-2013
• Figure 2-11: Per Head Healthcare Spending (US$), 2002-2008
• Figure 2-12: Forecast for Per Head Healthcare Spending (US$), 2009-2013
• Figure 2-13: Number of Doctors (per ' 000 Population), 2002-2008
• Figure 2-14: Forecast for Number of Doctors (2009-2013)
• Figure 2-15: Number of Hospital Beds (per ' 000 Population), 2002-2008
• Figure 2-16: Forecast for Number of Hospital Beds (per ' 000 Population), 2009-2013
• Figure 3-1: Prescriptions Dispensed in Pharmaceutical Market (Million), 2007 & 2008
• Figure 3-2: Pharmaceutical Sales (Billion CAD), 2005-2008
• Figure 3-3: Pharmaceutical Purchases by Retail and Hospital Pharmacies (Billion CAD), 2005-2008
• Figure 3-4: Deaths by Various Causes (%), 2005 & 2008
• Figure 3-5: Share of Generic and Branded Drug by Prescription (2008)
• Figure 3-6: Share of Generic and Branded Drug by Sales (2008)
• Figure 3-7: Drug Financing by Source (%), 2008
• Figure 4-1: Population above 65 Years of Age (Million), 2002-2008
• Figure 4-2: Average Cost of Branded and Generic Drug (CAD), 2002-2008
• Figure 5-1: Prescriptions Dispensed in Branded Drug Market (Million), 2002-2008
• Figure 5-2: Prescriptions Dispensed in Generic Drug Market (Million), 2002-2008
• Figure 5-3: Share of Generic and Branded Drug by Prescription (2002-2008)
• Figure 5-4: Generic Drug Sales (Billion CAD), 2002-2008
• Figure 5-5: Branded Drug Sales (Billion CAD), 2002-2008
• Figure 5-6: Share of Generic and Branded Drug by Sales (2002-2008)
• Figure 5-7: Branded Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
• Figure 5-8: Generic Drug Sales through Retail Pharmacies (Billion CAD), 2005-2008
• Figure 5-9: Share of Generic and Branded Drug Sales through Retail Pharmacies (2005-2008)
• Figure 5-10: Branded Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
• Figure 5-11: Generic Drug Sales through Hospital Pharmacies (Billion CAD), 2005-2008
• Figure 5-12: Share of Generic and Branded Drug Sales through Hospital Pharmacies (2005-2008)
• Figure 5-13: Share of Independent Generic and Authorized Generic Prescriptions (2002-2008)
• Figure 5-14: Generic Drug Market by Retail and Hospital Sales (%), 2008
• Figure 6-1: Cardiovascular Drug Market (Billion CAD), 2005-2008 & 2013
• Figure 6-2: Psychotherapeutics Market (Billion CAD), 2005-2008 & 2013
• Figure 6-3: Cholesterol Agents Market (Billion CAD), 2005-2008 & 2013
• Figure 6-4: Number of Diabetes Patients in Age Group 20-79 Years (' 000), 2003, 2008 & 2025
• Figure 6-5: Diabetes Therapy Market (Million CAD), 2005-2008 & 2013
• Figure 7-1: Forecast for Pharmaceutical Sales (Billion CAD), 2009-2013
• Figure 7-2: Forecast for Generic Drug Sales (Billion CAD), 2009-2013
• Figure 7-3: Forecast for Branded Drug Sales (Billion CAD), 2009-2013
• Figure 7-4: Forecast for Share of Branded and Generic Drugs by Prescription (2009-2013)
• Figure 7-5: Forecast for Share of Branded and Generic Drugs by Sales (2009-2013)
• Figure 7-6: Forecast for Contribution of Branded and Generic Drug Sales in Growth of Pharmaceutical Market (%), 2009 to 2013
• Figure 8-1: Relation between Brand Sales and Number of Generic Entrants

List of Tables:

• Table 3-1: Top Ten Therapy Areas by Prescription (' 000), 2008
• Table 3-2: Top Ten Therapy Areas by Sales (' 000 CAD), 2008
• Table 3-3: Top Twenty Drugs in Pharmaceutical Market by Prescription (Million), 2008
• Table 3-4: Top Ten Drugs in Pharmaceutical Market by Sales (Million CAD), 2007
• Table 4-1: Generic and Branded Drug Returns for Pharmacists (CAD)
• Table 5-1: Per Capita Drug Spending of Public and Private Sector by Region (CAD), 2008
• Table 5-2: Generic Drug Prescriptions Dispensed by Region (%), 2002-2008
• Table 5-3: Generic Drug Sales by Region (%), 2004 & 2006
• Table 5-4: Number of Retail Pharmacies by Category (2002-2008)
• Table 5-5: Top Ten Therapy Areas by Hospital Sales (Million CAD), 2008
• Table 5-6: Pharmaceutical Sales by Distribution Channel (%), 2002-2006
• Table 8-1: Top Pharmaceutical Companies by Retail Prescription (Million), 2006
• Table 8-2: Ranking of Top Pharmaceutical Companies by Retail Prescription (2004-2006)
• Table 8-3: Top Pharmaceutical Companies by Sales (Million CAD), 2008
• Table 8-4: Ranking of Top Pharmaceutical Companies by Sales (2006-2008)
• Table 8-5: Top Generic Drug Companies by Prescription (Million), 2007
• Table 8-6: Ranking of Top Generic Drug Companies by Prescription (2005-2007)
• Table 8-7: Top Generic Drug Companies by Sales (Million CAD), 2007
• Table 8-8: Ranking of Top Generic Drug Companies by Sales (2005-2007)
• Table 8-9: Ranking of Top Generic Companies by Retail Sales (2007)
• Table 8-10: Ranking of Top Generic Companies by Hospital Sales (2006)